Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 02, 2016

Impax Laboratories, Inc. v. Turing Pharmaceuticals AG

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 15, 2016

    NY Judge Looks To Trim Impax AIDS Drug Suit Against Turing

    A Manhattan federal judge said Friday he is inclined to cut a claim of unjust enrichment from Impax Laboratories' $30 million breach of contract case against Turing Pharmaceuticals, whose ex-leader Martin Shkreli jacked up the price of AIDS drug Daraprim, as the companies tangle over higher Medicaid costs tied to the infamous price hike.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login